INTELLIGENT BIO SOLUTIONS INC. Foreign Currency Transaction Gain (Loss), Realized
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Foreign Currency Transaction Gain (Loss), Realized of $39.82 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossRealized · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. foreign currency transaction gain (loss), realized for the quarter ending 2026-06-30 was $7.56K, a 251966.67% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. foreign currency transaction gain (loss), realized for the quarter ending 2026-03-31 was $32.26K.
- INTELLIGENT BIO SOLUTIONS INC. foreign currency transaction gain (loss), realized for the quarter ending 2025-06-30 was $3.00, a 99.20% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. foreign currency transaction gain (loss), realized for the quarter ending 2025-03-31 was -$113.00.
- INTELLIGENT BIO SOLUTIONS INC. foreign currency transaction gain (loss), realized for fiscal 2026 was $39.82K.
- INTELLIGENT BIO SOLUTIONS INC. foreign currency transaction gain (loss), realized for fiscal 2025 was -$911.00.
- INTELLIGENT BIO SOLUTIONS INC. foreign currency transaction gain (loss), realized for fiscal 2024 was -$1.18K.
- INTELLIGENT BIO SOLUTIONS INC. foreign currency transaction gain (loss), realized for fiscal 2023 was -$9.83K.
| Period end | Foreign Currency Transaction Gain (Loss), Realized 3 month | Foreign Currency Transaction Gain (Loss), Realized 6 month | Foreign Currency Transaction Gain (Loss), Realized 9 month | Foreign Currency Transaction Gain (Loss), Realized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.56K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $39.82K derived: sum of 2 quarters · filed 2026-08-19 | $39.82K 10-K · filed 2026-08-19 | |
| 2026-03-31 | $32.26K 10-Q · filed 2026-05-13 | $32.26K 10-Q · filed 2026-05-13 | ||
| 2025-06-30 | $3.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | -$110.00 derived: sum of 2 quarters · filed 2026-08-19 | -$860.00 derived: sum of 3 quarters · filed 2026-08-19 | -$911.00 10-K · filed 2026-08-19 |
| 2025-03-31 | -$113.00 10-Q · filed 2026-05-13 | -$863.00 derived: sum of 2 quarters · filed 2026-05-13 | -$914.00 10-Q · filed 2026-05-13 | -$541.00 derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$750.00 10-Q · filed 2026-02-12 | -$801.00 10-Q · filed 2026-02-12 | -$428.00 derived: sum of 3 quarters · filed 2026-02-12 | -$1.42K derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-09-30 | -$51.00 10-Q · filed 2025-11-12 | $322.00 derived: sum of 2 quarters · filed 2025-11-12 | -$674.00 derived: sum of 3 quarters · filed 2025-11-12 | -$1.23K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $373.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | -$623.00 derived: sum of 2 quarters · filed 2025-08-15 | -$1.18K derived: sum of 3 quarters · filed 2025-08-15 | -$1.18K 10-K · filed 2025-08-15 |
| 2024-03-31 | -$996.00 10-Q · filed 2025-05-13 | -$1.55K derived: sum of 2 quarters · filed 2025-05-13 | -$1.55K 10-Q · filed 2025-05-13 | |
| 2023-12-31 | -$555.00 10-Q · filed 2025-02-13 | -$555.00 10-Q · filed 2025-02-13 | ||
| 2023-06-30 | -$893.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | $6.32K derived: sum of 2 quarters · filed 2024-09-18 | -$7.58K derived: sum of 3 quarters · filed 2024-09-18 | -$9.83K 10-K · filed 2024-09-18 |
| 2023-03-31 | $7.21K 10-Q · filed 2024-05-08 | -$6.69K derived: sum of 2 quarters · filed 2024-05-08 | -$8.94K 10-Q · filed 2024-05-08 | -$9.83K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$13.90K 10-Q · filed 2024-02-09 | -$16.15K 10-Q · filed 2024-02-09 | -$17.04K derived: sum of 3 quarters · filed 2024-02-09 | -$17.03K derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-09-30 | -$2.25K 10-Q · filed 2023-11-08 | -$3.14K derived: sum of 2 quarters · filed 2023-11-08 | -$3.13K derived: sum of 3 quarters · filed 2023-11-08 | -$3.12K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$893.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | -$883.00 derived: sum of 2 quarters · filed 2023-08-23 | -$869.00 derived: sum of 3 quarters · filed 2023-08-23 | -$3.99K 10-K · filed 2023-08-23 |
| 2022-03-31 | $10.00 10-Q · filed 2023-05-11 | $24.00 derived: sum of 2 quarters · filed 2023-05-11 | -$3.09K 10-Q · filed 2023-05-11 | -$3.99K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $14.00 10-Q · filed 2023-02-14 | -$3.10K 10-Q · filed 2023-02-14 | -$4.00K derived: sum of 3 quarters · filed 2023-02-14 | $4.78K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | -$3.12K 10-Q · filed 2022-11-14 | -$4.01K derived: sum of 2 quarters · filed 2022-11-14 | $4.76K derived: sum of 3 quarters · filed 2022-11-14 | -$81.87K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$892.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | $7.88K derived: sum of 2 quarters · filed 2022-09-22 | -$78.75K derived: sum of 3 quarters · filed 2022-09-22 | -$271.23K 10-K · filed 2022-09-22 |
| 2021-03-31 | $8.77K 10-Q · filed 2022-05-16 | -$77.86K derived: sum of 2 quarters · filed 2022-05-16 | -$270.33K 10-Q · filed 2022-05-16 | |
| 2020-12-31 | -$86.64K 10-Q · filed 2022-02-11 | -$279.11K 10-Q · filed 2022-02-11 | ||
| 2020-09-30 | -$192.47K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |